Redpoint Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$539K Sell
8,354
-3,196
-28% -$221K 0.08% 302
2022
Q2
$800K Sell
11,550
-158
-1% -$11.7K 0.09% 262
2022
Q1
$899K Buy
11,708
+1,479
+14% +$106K 0.09% 264
2021
Q4
$783K Hold
10,229
0.06% 349
2021
Q3
$755K Sell
10,229
-909
-8% -$68.2K 0.06% 345
2021
Q2
$743K Buy
11,138
+2,274
+26% +$152K 0.06% 355
2021
Q1
$659K Buy
+8,864
New +$673K 0.06% 370
2020
Q4
Sell
-7,324
Closed -$487K 594
2020
Q3
$487K Hold
7,324
0.05% 352
2020
Q2
$417K Buy
+7,324
New +$359K 0.02% 456
2020
Q1
Sell
-5,628
Closed -$294K 568
2019
Q4
$294K Hold
5,628
0.01% 519
2019
Q3
$284K Hold
5,628
0.02% 509
2019
Q2
$270K Hold
5,628
0.01% 529
2019
Q1
$272K Hold
5,628
0.01% 531
2018
Q4
$231K Hold
5,628
0.01% 531
2018
Q3
$231K Hold
5,628
0.01% 555
2018
Q2
$224K Hold
5,628
0.01% 513
2018
Q1
$210K Hold
5,628
0.01% 514
2017
Q4
$241K Buy
+5,628
New +$224K 0.01% 488

Other funds holding HOLX

Redpoint Investment Management's HOLX Position: Q3 2022 in Review

Redpoint Investment Management reduced its Hologic (HOLX) stake by 28% in Q3 2022, selling an estimated $221K and leaving 8,354 shares worth $539K. The position accounts for 0.08% of the portfolio, ranked #302.

Redpoint Investment Management first reported a position in HOLX in Q4 2017 and has held it in 18 quarters since. The position peaked at $899K in Q1 2022. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Redpoint Investment Management held 8,354 shares of Hologic worth $539K as of Q3 2022.
  • Redpoint Investment Management sold 3,196 Hologic shares in Q3 2022, an estimated $221K.
  • Hologic made up 0.08% of Redpoint Investment Management's portfolio in Q3 2022, its #302 holding.
  • Redpoint Investment Management first reported a position in Hologic in Q4 2017 and has held it in 18 quarters since.
  • Redpoint Investment Management's Hologic position peaked at $899K in Q1 2022.
  • 654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.